Ahmed M Elkhanany (Ahmed Elkhanany)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 11

Top Topics

Polycystic Ovary Syndrome

Metastatic Breast Cancer

Top Venues

Breast cancer research and treatment

NPJ breast cancer

Journal of the National Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Publications

Brooke B Bartow, Gene P Siegal, Ceren Yalniz, Ahmed M Elkhanany, Lei Huo, Qingqing Ding, Aysegul A Sahin, Hua Guo, Cristina Magi-Galluzzi, Shuko Harada, Xiao Huang
Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Cancers 15 (9) (2023)
Brooke B Bartow, Gene P Siegal, Ceren Yalniz, Ahmed M Elkhanany, Lei Huo, Qingqing Ding, Aysegul A Sahin, Hua Guo, Cristina Magi-Galluzzi, Shuko Harada, Xiao Huang
Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma. Cancers 15 (9) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Sibel Blau, Julio Antonio Peguero, Halle C F Moore, Ian Churchill Anderson, Minal A Barve, Mathew Amprayil Cherian, Ahmed M Elkhanany, Ciara Catherine O'Sullivan, Alvaro Moreno-Aspitia, Paul Plourde, Lyon L Gleich, Kendra Riesen, Ross Ezzati, Meghan Degele, Megan Shulman, Stephanie Dobson Stempf, Laura Sachse, Amrita A Iyer, Senthil Damodaran, Matthew M Cooney
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model. JCO clinical cancer informatics 7 (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment 198 (2) (2023)
Christos Vaklavas, Erica M Stringer-Reasor, Ahmed M Elkhanany, Kevin J Ryan, Yufeng Li, Charles P Theuer, Edward P Acosta, Shi Wei, Eddy Shih-Hsin Yang, William E Grizzle, Andres Forero-Torres
A phase I/II study of preoperative letrozole, everolimus, and carotuximab in stage 2 and 3 hormone receptor-positive and Her2-negative breast cancer. Breast cancer research and treatment (2023)
Neelima Vidula, Andrew Lipman, Shumei Kato, Caroline Weipert, Katherine Hesler, Georges Azzi, Ahmed M Elkhanany, Dejan Juric, Estelamari Rodriguez, Colleen Faulkner, Paul Makhlouf, Kristin Price, Joyce O'Shaughnessy, Aditya Bardia
Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancer. NPJ breast cancer 8 (1) (2022)
Song Yao, Ting-Yuan David Cheng, Ahmed M Elkhanany, Li Yan, Angela R Omilian, Scott I Abrams, Sharon Evans, Chi-Chen Hong, Qianya Qi, Warren Davis, Song Liu, Elisa V Bandera, Kunle Odunsi, Kazuaki Takabe, Thaer Khoury, Christine B Ambrosone
Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion. Journal of the National Cancer Institute 113 (8) (2022)